Andrew Siemion to receive the SETI Institute’s 2024 Drake Award

The Drake Award celebrates remarkable achievements in the realms of SETI and astrobiology

2024-03-28

(Press-News.org) March 28, 2024, Mountain View, CA -- The SETI Institute is pleased to announce that Dr. Andrew Siemion will be honored with the prestigious 2024 Drake Award for his exceptional and pioneering contributions to SETI and radio astronomy and his leadership in the field. Siemion's distinguished career includes his role as the Bernard M. Oliver Chair for SETI at the SETI Institute, Principal Investigator for the Breakthrough Listen Initiative at the University of Oxford, along with holding an Honorary Professorship at the University of Manchester, an Adjunct Appointment at the University of Malta, and directing the Berkeley SETI Research Center at the University of California, Berkeley. His dedication to SETI science and funding has been crucial in advocating for the scientific validity and importance of the field.

Named after Dr. Frank Drake, the SETI Institute's inaugural president of its Board of Trustees and the architect of the Drake Equation, the Drake Award celebrates remarkable achievements in the realms of SETI and astrobiology. Drake, often heralded as the father of SETI, launched the first SETI experiment, Project Ozma, at the Green Bank Radio Observatory in 1960, and his Drake Equation has become a fundamental framework for astrobiology. Drake Award recipients are nominated by the SETI Institute's Science Advisory Board and ratified by its Board of Trustees. The 2024 Drake Award presentation marks a significant occasion as it continues to honor the legacy of Dr. Drake following his passing in 2022.

“It is profoundly humbling to receive an award named after Frank Drake,” said Siemion. “I was privileged to know Frank as both a friend and a colleague, and his immense generosity of spirit and scientific curiosity made an indelible imprint on me as a scientist and human. As we mark the 40th anniversary of the SETI Institute and look toward the next forty years in the search for technologically capable life, we see how far Frank's vision and leadership have brought us and the amazing opportunities for discovery ahead."

"Andrew Siemion, in a still young career, has become one of the world's most prominent and productive SETI researchers," said Bill Diamond, CEO of the SETI Institute. "From leading the transformation of the Allen Telescope Array to world-class status to conceiving the COSMIC project on the VLA to presiding over the Breakthrough Listen initiative, Andrew has transformed the field of radio SETI research and left his permanent mark on this profound endeavor. We are delighted to honor Andrew as our 2024 Drake Award recipient."

Siemion received his AB (2008), MA (2010) and Ph.D. (2012) in Astrophysics from the University of California, Berkeley, during which he received a Josephine De Karman Fellowship, the Dorothea Klumpke Roberts Award and the Mary Elizabeth Uhl Dissertation Prize for his work in astronomical instrumentation and the search for extraterrestrial intelligence.

Since its inception in 2001, extraordinary individuals such as Frank Drake, Charles Townes, William Borucki, Victoria Meadows, Jason Wright, Paul Horowitz, Dan Werthimer, Shelley Wright and John Rummel have received the Drake Award for their groundbreaking contributions.

The 2024 Drake Awards ceremony is scheduled for May 16, 2024, at the Computer History Museum in Mountain View, CA, at a public event. The SETI Institute will also livestream the event via Zoom for those unable to attend in person. Dr. Moiya McTier, an astrophysicist, folklorist, and author, will host the event. In addition to the Drake Award, the ceremony will include the presentation of the SETI Forward Award, which encourages future scientists in their pursuit of life in the universe, and the Carl Sagan Director's Award, recognizing exceptional contributions to astrobiology, technology, and the exploration of life in the universe.

Registration and information for this event can be found:

In Person Ticket Page: https://events.idonate.com/drakeawards2024 Virtual Ticket Page: https://events.idonate.com/drakeawardsvirtual2024 Table Sponsor Page: https://gift.idonate.com/seti/tablehost2024

About the SETI Institute
Founded in 1984, the SETI Institute is a non-profit, multi-disciplinary research and education organization whose mission is to lead humanity’s quest to understand the origins and prevalence of life and intelligence in the Universe and to share that knowledge with the world. Our research encompasses the physical and biological sciences and leverages expertise in data analytics, machine learning and advanced signal detection technologies. The SETI Institute is a distinguished research partner for industry, academia and government agencies, including NASA and NSF.

Contact information
Rebecca McDonald
Director of Communications
SETI Institute
rmcdonald@seti.org

END

[Attachments] See images for this press release:

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award 2

ELSE PRESS RELEASES FROM THIS DATE:

New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells

2024-03-28

Researchers at Karolinska Institutet, in collaboration with JLP Health and others, have identified how the tick-borne Crimean-Congo haemorrhagic fever virus enters our cells. The results are published in Nature Microbiology and are an important step in the development of drugs against the deadly disease. Crimean-Congo haemorrhagic fever virus (CCHF virus) is spread through tick bites and can cause haemorrhagic fever. The disease is serious and has a mortality rate of up to 40 per cent depending on the health status of the person infected. Common symptoms ...

Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma

2024-03-28

In a recent multi-center study published in the Journal of the National Cancer Institute, researchers examined the effects of neoadjuvant chemotherapy (NAC) on patients suffering from locally advanced penile squamous cell carcinoma (PSCC). Dr. Kyle Rose, urologic oncologist at Ochsner MD Anderson Cancer Center, was the lead author for the publication. The research included a cohort of 209 patients undergoing NAC, targeting locally advanced and clinically node positive PSCC. The patient group showed a diverse range of disease severity, with a distribution including 7% with stage II, 48% with stage III, and 45% with stage IV PSCC, ...

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes

2024-03-28

(MEMPHIS, Tenn. – March 28, 2024) Resistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Children’s Research Hospital scientists demonstrated that in bilateral Wilms tumor (cancer in both kidneys) chemotherapy resistance can point toward a more favorable histology and an ultimatelygood outcome. The study revealed that tumors that do not respond to neoadjuvant, or tumor-shrinking, chemotherapy are predominantly ...

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

2024-03-28

HERSHEY, Pa. — Despite evidence that financial conflicts of interest may influence medical practice and research and may erode patient trust in medical professionals, these relationships remain pervasive. According to a new analysis of the Open Payments platform, a database that tracks payments between physicians and industry, a team led by a Penn State researcher found that doctors received approximately $12.1 billion from drug and device makers between 2013 and 2022. Their findings published today (March 28) in JAMA. It’s one of the first studies to look at industry payments longitudinally and by specialty. “Overall, ...

Discovery suggests new strategy against follicular lymphoma

2024-03-28

A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients. The study, published March 7 in Cancer Cell, showed that while mutations affecting a gene-regulating complex called BAF can put the cancer on a dangerous trajectory, they also make follicular lymphoma highly susceptible to experimental BAF-inhibitor drugs. “These encouraging findings could address critical and urgent challenges with this disease and have prompted us to begin planning clinical trials ...

Making the future too bright: how wishful thinking can point us in the wrong direction

2024-03-28

Everyone indulges in wishful thinking now and again. But when is that most likely to happen and when could it actually be harmful? A new study, led by the University of Amsterdam (UvA), demonstrates unequivocally that the greater the insecurity and anxiety of a situation, the more likely people are to become overly optimistic – even to the point where it can prevent us from taking essential action. The study's results have now been published in the journal American Economic Review. ‘People aren't purely truth-seekers - many beliefs are influenced by ...

Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters

2024-03-28

NEW ORLEANS, La – Newsweek and Plant-A Insights Group have named Ochsner Health one of America's Greatest Workplaces for Job Starters in 2024. In a survey that included more than 75,000 young professionals and more than 540,000 company reviews, Ochsner earned 5 out of 5 stars. As the leading not-for-profit healthcare provider in the Gulf South, Ochsner is committed to championing career development among new professionals. "We at Ochsner are honored to receive recognition as a place of employment that offers ...

Three-year study of young stars with NASA’s Hubble enters new chapter

2024-03-28

In the largest and one of the most ambitious Hubble Space Telescope programs ever executed, a team of scientists and engineers collected information on almost 500 stars over a three-year period. This effort offers new insights into the stars' formation, evolution, and impact on their surroundings. This comprehensive survey, called ULLYSES (Ultraviolet Legacy Library of Young Stars as Essential Standards), was completed in December 2023, and provides a rich spectroscopic dataset obtained in ultraviolet light that astronomers will be mining for decades to come. Because ultraviolet light can ...

North Carolina takes the lead in PFAs research with Collaboratory’s $3 million investment to expand the state’s research capacity

2024-03-28

WILMINGTON, N.C. (March 27, 2024) – The North Carolina Collaboratory – an organization dedicated to advancing scientific research for policymaking within North Carolina – today announced its partnership with Thermo Fisher Scientific to advance the State’s per- and polyfluoroalkyl substances (PFAS) research capabilities. Supported by critical appropriations from the North Carolina General Assembly (NCGA), the Collaboratory purchased five state-of-the-art mass spectrometers that continue to position North Carolina at the forefront of academic PFAS research nationally. This new partnership ...

Is it the school, or the students?

2024-03-28

Are schools that feature strong test scores highly effective, or do they mostly enroll students who are already well-prepared for success? A study co-authored by MIT scholars concludes that widely disseminated school quality ratings reflect the preparation and family background of their students as much or more than a school’s contribution to learning gains. Indeed, the study finds that many schools that receive relatively low ratings perform better than these ratings would imply. Conventional ...

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: